January2017

News Hour: Ahead of the keynote address by Richard Yu, CEO of Huawei Consumer Business Group (CBG) at CES 2017, CBG announced that the company has shipped more than 10 million Huawei P9 and P9 Plus...

News Hour: Mexico’s central bank confirmed on Friday it had sold dollars during the Asian trading session on Friday, its second intervention the day after it did the same during Mexican and U.S. trading hours to...

News Hour: At last 33 inmates have been killed in a new prison riot in the Amazon region of Brazil, officials said on Friday, just five days after 56 inmates were slaughtered in the country’s worst...

News Hour: Bitcoin plunged another 12 percent on Friday after China’s central bank urged investors to take a rational approach to the digital currency, which has is on track for its heaviest two-day falls in two...

News Hour: Oil prices edged higher on Friday as output cuts by OPEC members met with lingering concern that other producers could try to shirk their share of planned decreases aimed at curbing global oversupply. Brent...

News Hour: J.C. Penney Co Inc said same-store sales for November and December fell 0.8 percent, the latest department store chain to report a disappointing holiday season performance. The company’s shares fell as much as 5.8 percent...

News Hour: South Korea’s LG Electronics Inc estimated on Friday it fell to its first quarterly operating loss in six years in October-December, a drop that analysts pinned on continued mobile losses and seasonally weaker appliances...

News Hour: Chinese telecom equipment maker ZTE, which is facing U.S. trade sanctions that could severely disrupt its supply chain, is slashing about 3,000 jobs, including a fifth of positions in its struggling handset business in...

News Hour: Workers wearing masks and protective clothes gassed thousands of ducks in southwest France on Friday, in a massive cull that was ordered in an attempt to prevent a spread of the H5N5 bird flu...

News Hour: Novartis has agreed with Ionis Pharmaceuticals Inc and its affiliate Akcea Therapeutics Inc to license two experimental cardiovascular treatments in a deal which Ionis said could eventually be worth more than $1 billion. The...